EUROCARE-4

88. Comparative cancer survival information in Europe
    Berrino F.; Verdecchia A.; Lutz J.M.; Lombardo C.; Micheli A.; Capocaccia R.;
    the EUROCARE Working Group.
    European Journal of Cancer 2009,45:901-908. Document

87. The EUROCARE-4 database on cancer survival in Europe: Data standardisation, quality control and methods of statistical analysis
    De Angelis R.; Francisci S.; Baili P.; Marchesi F.; Roazzi P.; Belot A.;
    the EUROCARE Working Group et al.
    European Journal of Cancer 2009,45:909-930. Document

86. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999.
    Results and commentary
    Sant M.; Allemani C.; Santaquilani M.; Knijn A.; Marchesi F.; Capocaccia R.; 
    the EUROCARE Working Group.
    European Journal of Cancer 2009,45:931-991. Document

85. Survival of European children and young adults with cancer
    diagnosed 1995-2002
    Gatta G.; Zigon G.; Capocaccia R.; Coebergh J.W.; Desandes E.; Kaatsch P.; 
    Pastore G.; Peris-Bonet R.; Stiller C.A.; the EUROCARE Working Group.
    European Journal of Cancer 2009,45:992-1005. Document

84. The cancer survival gap between elderly and middle-aged patients
    in Europe is widening
    Quaglia A.; Tavilla A.; Shack L.; Brenner H.; Janssen-Heijnen M.; Allemani C.; 
    Colonna M.; Grande E.; Grosclaude P.; Vercelli M.; the EUROCARE Working Group.
    European Journal of Cancer 2009,45:1006-1016. Document

83. The advantage of women in cancer survival: An analysis of EUROCARE-4 data
    Micheli A.; Ciampichini R.; Oberaigner W.; Ciccolallo L.; de Vries E.; Izarzugaza I.; 
    Zambon P.; Gatta G.; De Angelis R.; the EUROCARE Working Group.
    European Journal of Cancer 2009,45:1017-1027. Document

82. Long-term survival expectations of cancer patients in Europe in 2000-2002
    Brenner H.; Francisci S.; De Angelis R.; Marcos-Gragera R.; Verdecchia A.; 
    Gatta G.; Sant M.; the EUROCARE Working Group et al.
    European Journal of Cancer 2009,45:1028-1041. Document

81. Survival trends in European cancer patients diagnosed form 1988 to 1999
    Verdecchia A.; Guzzinati S.; Francisci S.; De Angelis R.; Bray F.; Allemani C.; 
    Tavilla A.; Santaquilani M.; Sant M.; the EUROCARE Working Group.
    European Journal of Cancer 2009,45:1042-1066. Document

80. The cure of cancer: A European perspective
    Francisci S.; Capocaccia R.; Grande E.; Santaquilani M.; Simonetti A.; Allemani C.; 
    Gatta G.; Sant M.; Zigon G.; Bray F.; Janssen-Heijnen M.; the EUROCARE Working Group.
    European Journal of Cancer 2009,45:1067-1079. Document

79. Multiple tumours in survival estimates
    Rosso S.; De Angelis R.; Ciccolallo L.; Carrani E.; Soerjomataram I.; Grande E.; Zigon G.;
    Brenner H.;  the EUROCARE Working Group.
    European Journal of Cancer 2009,45:1080-1094. Document

78. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data
    Verdecchia A.; Francisci S.; Brenner H.; Gatta G.; Micheli A.; Mangone L. et al.
    Lancet Oncology 2007,8:784-796. Document

77. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study
    Berrino F.; De Angelis R.; Sant M.; Rosso S.; Lasota M.B.; Coebergh J.W. et al.
    Lancet Oncology 2007,8:773-783. Document

 (top...)

EUROCARE-3

76. Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States
    Sant. M.; Allemani C.; De Angelis R.; Carbone A.; De Sanjosè S.; Gianni A.M.; Giraldo P.; Marchesi F.; Marcos-Gragera R.; Martos-jimenez C.; Maynadié M.; Raphael M.; Berrino F.;
    EUROCARE-3 Working Group.
    European Journal of Cancer 2008, 44:579-587. Document

75. Incidence of Uveal Melanoma in Europe
    Virgili G.; Gatta G.; Ciccolallo L.; Capocaccia R.; Buggeri A. et al.
    Ophthalmology 2007,114:2309-2315. Document

74. Hepatocellular carcinoma: trends of incidence and survival in Europe and United States at the end of the 20th century
    Capocaccia R.; Sant M.; Berrino F.; Simonetti A.; Santi V.; Trevisani F. et al.
    American Journal of Gastroenterology 2007,102:1661-1670. Document

73. Trends in cervical cancer survival in Europe, 1983-1994: A population-based study
    Lasota M.B.; Inghelmann R.; Van de Poll-Franse L.; Capocaccia R.; the EUROCARE Working Group.
    Gynecologic Oncology 2007,105:609-619. Document

72. A wide difference in cancer survival between middle aged and elderly patients in Europe
    Quaglia A.; Capocaccia R.; Micheli A.; Carrani E.; Vercelli M.; and the EUROCARE-3 Working Group.
    International Journal of Cancer 2007,120:2196-2201. Document

71. Hodgkin disease survival in Europe and the U.S.
    Allemani C.; Sant M.; De Angelis R.; Gragera R.M.; Coebergh J.W.; and the Eurocare Working Group.
    Cancer 2006,107:352-360. Document

70. Variation in relative survival of thyroid cancers in Europe: Results from the analysis on 21 countries over the period 1983-1994(EUROCARE-3 study)
    Colonna M.; Grande E.; Jonasson J.G.; EUROCARE Working Group.
    European Journal of Cancer 2006,42:2598-2608. Document

69. Incidence of and survival from Wilms' tumour in adults in Europe: Data from the EUROCARE study
    Emmanuel M.; Ciccolallo L.; Coleman M.P.; Gatta G.; Pritchard-Jones K.; EUROCARE Working Group.
    European Journal of Cancer 2006,42:2363-2368. Document

68. Survival from rare cancer in adults: a population-based study
    Gatta G.; Ciccolallo L.; Kunkler I.; Capocaccia R.; Berrino F.; Coleman M.P. et al.
    Lancet Oncology 2006,7:132-140. Document

67. Seasonal variation in the occurrence of cutaneous melanoma in Europe: influence of latitude. An analisis using the EUROCARE group of registries
    Boniol M.; De Vries E.; Coebergh J.W.; Dore, J.F.; EUROCARE Working Group.
    European Journal of Cancer 2005,41:126-132. Document

66. Childhood cancer survival trends in Europe: A EUROCARE Working Group Study
    Gatta G.; Capocaccia R.; Stiller C.; Kaatsh P.; Berrino F.; Terenziani M. et al.
    Journal of Clinical Oncology 2005,23:3742-3751. Document

65. Explaining gastric cancer survival differences among european countries
    Verdecchia A.; Corazziari I.; Gatta G.; Lisi D.; Faivre J.; Forman D. et al.
    International Journal of Cancer 2004,109:737-741. Document

64. Lower incidence rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe
    De Vries E.; Boniol M.; Dore, J.F.; Coebergh J.W.; EUROCARE Working Group.
    European Journal of Cancer 2004,40:1045-1052. Document

63. Breast carcinoma survival in Europe and the United States – A population-based study
    Sant M.; Allemani C.; Berrino F.; Coleman M.P.; Aareleid T. et al.
    Cancer 2004,100:715-722. Document

62. Cancer survival in European adolescents and young adults
    Gatta G.; Capocaccia R.; De Angelis R.; Stiller C.; Coebergh J.W.
    European Journal of Cancer 2003,39:2600-2610. Document

61. Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology
    Gatta G.; Ciccolallo L.; Capocaccia R.; Coleman M.P.; Hakulinen T.; Møller H.; Berrino F.
    European Journal of Cancer 2003,39:2214-2222. Document

60. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe
    Sant M.; Allemani C.; Capocaccia R.; Hakulinen T.; Aareleid T.; Coebergh J.W.;
    Coleman M.P.; Grosclaude P.; Martinez C.; Bell J.; Youngson J.; Berrino F.
    International Journal of Cancer 2003,106:416-422. Document

59. Electronic availability of EUROCARE-3 data: a tool for further analysis
    Roazzi P.; Capocaccia R.; Santaquilani M.; Carrani E.
    Annals of Oncology 2003,14:v150-v155. Document

58. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century
    Coleman M. P.; Gatta G.; Verdecchia A.; Estève J.; Sant M.; Storm H.; Allemani C.; Ciccolallo L.; Santaquilani M.; Berrino F.
    Annals of Oncology 2003,14:v128-v149. Document

57. Childhood cancer survival in Europe
    Gatta G.; Corazziari I.; Magnani C.; Peris-Bonet R.; Roazzi P.; Stiller C.
    Annals of Oncology 2003,14:v119-v127. Document

56. EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary
    Sant M.; Aareleid T.; Berrino F.; Lasota M.B.; Carli P.M.; Faivre J.; Grosclaude P.;
    Hédelin G.; Matsuda T.; Møller H.; Möller T.; Verdecchia A.; Capocaccia R.; et al.
    Annals of Oncology 2003,14:v61-v118. Document

55. European health systems and cancer care
    Micheli A.; Coebergh J. W.; Mugno E.; Massimiliani E.; Sant M.; Oberaigner W.; Holub J.; Storm H. H.; Forman D.; Quinn M.; Aareleid T.; Sankila R.; Hakulinen T.; et al.
    Annals of Oncology 2003,14:v41-v60. Document

54. Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas
    Micheli A.; Baili P.; Quinn M.; Mugno E.; Capocaccia R.; Grosclaude P.
    Annals of Oncology 2003,14:v28-v40. Document

53. The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis
    Capocaccia R.; Gatta G.; Roazzi P.; Carrani E.; Santaquilani M.; De Angelis R.; Tavilla A.
    Annals of Oncology 2003,14:v14-v27. Document

52. The EUROCARE Study: strengths, limitations and perspectives of population-based, comparative survival studies
    Berrino F.
    Annals of Oncology 2003,14:v9-v13. Document

 (top...)

EUROPREVAL

51. Cancer prevalence in Northern Europe: the EUROPREVAL study
    Möller T.; Anderson H.; Aareleid T.; Hakulinen T.; Storm H.; Tryggvadottir L.; Corazziari I.; Mugno E.
    Annals of Oncology 2003,14:946-957. Document

50. Cancer prevalence in the UK: results from the EUROPREVAL study
    Forman D.; Stockton D.; Møller H.; Quinn M.; Babb P.; De Angelis R.; Micheli A.
    Annals of Oncology 2003,14:648-654. Document

49. Cancer prevalence in central Europe :the EUROPREVAL study
    Lutz J.M.; Francisci S.; Mugno E.; Usel M.; Pompe-Kirn V.; Coebergh J.W.; Bieslka-Lasota M.;
    On behalf of the EUROPREVAL Working Group.
    Annals of Oncology 2003,14:313-322. Document

48. A comparative analysis of cancer prevalence in cancer registry areas of France,
    Italy and Spain
    Verdecchia A.; Micheli A.; Colonna M.; Moreno V.; Izarzugaza M.I.; Paci E.
    Annals of Oncology 2002,13:1128-1139. Document

47. Cancer Prevalence in European Registry Areas
    Micheli A.; Mugno E.; Krogh V.; Quinn M.J.; Coleman M.; Hakulinen T.; Gatta G.;
    Berrino F.; Capocaccia R.
    Annals of Oncology 2002,13:840-865. Document

46. Measuring cancer prevalence in Europe: the EUROPREVAL Project
    Capocaccia R.; Colonna M.; Corazzieri I.; De Angelis R.; Francisci S.; Micheli A.; Mugno E.
    Annals of Oncology 2002,13:831-839. Document

 (top...)

EUROCARE-2

45. Cancer Survival Differences Between European Populations: the UK Uneasiness
    Gatta G.; Capocaccia R.; and Berrino F.
    British Journal of Cancer 2001,85:785-786. Document

44. Cancer Survival
    Forman D.; Gatta G.; Capocaccia R.; Janssen-Heijnen M.L.G.; and Coebergh J.W.W.
    Lancet 2001,357:555. Document

43. Cancer survival increases in Europe, but international differences remain wide
    Sant M.; Capocaccia R.; Coleman M.P.; Berrino F.; Gatta G.; Micheli A.; Verdecchia A.; et. al.
    European Journal of Cancer 2001,37:1659-1667. Document

42. Childhood cancer survival in Europe and the United States
    Gatta G.; Capocaccia R.; Coleman M.P.; Gloeckler Ries L.A.; Berrino F.
    Cancer 2002,95:1767-1772. Document

41. Childhood cancer survival in Europe: an overview
    Terracini B.; Coebergh J.-W.; Gatta G.; Magnani C.; Stiller C.; Verdecchia A.; Zappone A.
    European Journal of Cancer 2001,37:810-816. Document

40. Childhood cancer mortality in Europe, 1955–1995
    Levi F.; La Vecchia C.; Negri E.; Lucchini F.
    European Journal of Cancer 2001,37:785-809. Document

39. Childhood melanoma in Europe since 1978: a population-based survival study
    Conti E.M.S.; Cercato M.C.; Gatta G.; Ramazzotti V.; Roscioni S.
    European Journal of Cancer 2001,37:780-784. Document

38. Survival of children with thyroid cancer in Europe 1978–1989
    Storm H.H.; Plesko I.
    European Journal of Cancer 2001,37:775-779. Document

37. Survival of children with soft-tissue sarcoma in Europe since 1978: results from the EUROCARE study
    Stiller C.A.; Stevens M.C.G.; Magnani C.; Corazziari I.
    European Journal of Cancer 2001,37:767-774. Document

36. Survival of children with bone sarcoma in Europe since 1978: results from
    the EUROCARE study
    Stiller C.A.; Craft A.W.; Corazziari I.
    European Journal of Cancer 2001,37:760-766. Document

35. Survival of children with malignant germ cell, trophoblastic and other gonadal tumours in Europe
    Kramárová E.; Mann J.R.; Magnani C.; Corraziari I.; Berrino F.
    European Journal of Cancer 2001,37:750-759. Document

34. Survival of children with liver tumours in Europe 1978–1989
    Möller T.R.; Garwicz S.; Corazziari I.; Magnani C.
    European Journal of Cancer 2001,37:744-749. Document

33. Survival of children with Wilms' tumour in Europe
    Pleško I.; Kramárová E.; Stiller C.A.; Coebergh J.-W.; Santaquilani M.
    European Journal of Cancer 2001,37:736-743. Document

32. Survival for retinoblastoma in Europe
    Sant M.; Capocaccia R.; Badioni V.
    European Journal of Cancer 2001,37:730-735. Document

31. Survival of children with neuroblastoma: time trends and regional differences in Europe, 1978–1992
    Spix C.; Aareleid T.; Stiller C.; Magnani C.; Kaatsch P.; Michaelis J.
    European Journal of Cancer 2001,37:722-729. Document

30. Variation in survival of children with central nervous system (CNS) malignancies diagnosed in Europe between 1978 and 1992: the EUROCARE study
    Magnani C.; Aareleid T.; Viscomi S.; Pastore G.; Berrino F.
    European Journal of Cancer 2001,37:711-721. Document

29. Survival of childhood lymphomas in Europe, 1978–1992: a report from
    the EUROCARE study
    Pastore G.; Magnani C.; Verdecchia A.; Pession A.; Viscomi S.; Coebergh J.W.W.
    European Journal of Cancer 2001,37:703-710. Document

28. Survival from acute non-lymphocytic leukaemia (ANLL) and chronic myeloid leukaemia (CML) in European children since 1978: a population-based study
    Gatta G.; Luksch R.; Coleman M.P.; Corazziari I.
    European Journal of Cancer 2001,37:695-702. Document

27. Variation in survival of European children with acute lymphoblastic leukaemia, diagnosed in 1978–1992: the EUROCARE study
    Coebergh J.W.; Pastore G.; Gatta G.; Corazziari I.; Kamps W.
    European Journal of Cancer 2001,37:687-694. Document

26. Childhood malignancies in the EUROCARE study: the database and the methods of survival analysis
    Magnani C.; Gatta G.; Corazziari I.; Kramarova E.; Pastore G.; Viscomi S.; Stiller C.
    European Journal of Cancer 2001,37:678-686. Document

25. The EUROCARE study of survival of cancer patients in Europe: aims, current status, strengths and weaknesses
    Berrino F.; Gatta G.; Sant M.; Capocaccia R.
    European Journal of Cancer 2001,37:673-677. Document

24. Childhood cancer survival in Europe, 1978–1992: The EUROCARE Study
    Coebergh J.W.W.; Capocaccia R.; Gatta G.; Magnani C.; Stiller C.A.
    European Journal of Cancer 2001,37:671-672. Document

23. Toward a Comparison of Survival in American and European Cancer Patients
    Gatta G.; Capocaccia R.; Coleman MP.; Gloeckler Ries L.A.; Hakulinen T.; Micheli A.; Sant M.; Verdecchia A.; and Berrino F.
    Cancer 2000;89:893-900. Document

22. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study
    Gatta G.; Capocaccia R.; Sant M.; Bell C.M.J.; Coebergh J.W.W.; Damhuis R.A.M.; Faivre J.; Martinez-Garcia C.; Pawlega J.; Ponz de Leon M.; Pottier D.; Raverdy N.; Williams E.M.I.; Berrino F.
    Gut 2000,47:533-538. Document

21. Survival of cancer patients in Europe: the EUROCARE-2 Study
    Berrino F.; Capocaccia R.; Estève J.; Gatta G.; Hakulinen T.; Micheli A.; Sant M.;
    Verdecchia A. (editors)
    IARC Scientific Publication 1999,151.

20. Mixture models for cancer survival analysis: application to population-based data with covariates
    De Angelis R.; Capocaccia R.; Hakulinen T.; Soderman B.; Verdecchia A.
    Statistics in Medicine 1999,18:441-454. Document

19. Survival rates for primary malignant brain tumours in Europe
    Sant M.; van der Sanden G.; Capocaccia R.
    European Journal of Cancer 1998,34:2241-2247. Document

18. Improved survival for patients with testicular cancer in Europe since 1978
    Aareleid T.; Sant M.; Hédelin G.
    European Journal of Cancer 1998,34:2236-2240. Document

17. Improvement in survival of patients with cancer of the kidney in Europe
    Damhuis R.A.M.; Kirkels W.J.
    European Journal of Cancer 1998,34:2232-2235. Document

16. Variation in survival of patients with prostate cancer in Europe since 1978
    Post P.N.; Damhuis R.A.M.; Van der Meyden A.P.M.
    European Journal of Cancer 1998,34:2226-2231. Document

15. Survival of European women with gynaecological tumours, during the period 1978–1989
    Gatta G.; Lasota M.B.; Verdecchia A.
    European Journal of Cancer 1998,34:2218-2225. Document

14. Survival of adult patients with cancer of soft tissues or bone in Europe
    Storm H.H.; EUROCARE Working Group.
    European Journal of Cancer 1998,34:2212-2217. Document

13. Variations in survival from breast cancer in Europe by age and country, 1978–1989
    Quinn M.J.; Martinez-Garcia C.; Berrino F.
    European Journal of Cancer 1998,34:2204-2211. Document

12. Improving survival of melanoma patients in Europe since 1978
    Smith J.A.E.; Whatley P.M.; Redburn J.C.
    European Journal of Cancer 1998,34:2197-2203. Document

11. Variation in survival of patients with lung cancer in Europe, 1985–1989
    Janssen-Heijnen M.L.G.; Gatta G.; Forman D.; Capocaccia R.; Coebergh J.W.W.
    European Journal of Cancer 1998,34:2191-2196. Document

10. Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe
    Faivre J.; Forman D.; Estève J.; Obradovic M.; Sant M.
    European Journal of Cancer 1998,34:2184-2190. Document

9. Survival of colorectal cancer patients in Europe during the period 1978–1989
   Gatta G.; Faivre J.; Capocaccia R.; Ponz de Leon M.
   European Journal of Cancer 1998,34:2176-2183. Document

8. Survival of patients with oesophageal and gastric cancers in Europe
   Faivre J.; Forman D.; Estève J.; Gatta G.
   European Journal of Cancer 1998,34:2167-2175. Document

7. Variation in survival for adults with Nasopharyngeal cancer in Europe, 1978–1989
   Jiong L.; Berrino F.; Coebergh J.W.W.
   European Journal of Cancer 1998,34:2162-2166. Document

6. Variation in survival of patients with head and neck cancer in Europe
   by the site of origin of the tumours
   Berrino F.; Gatta G.
   European Journal of Cancer 1998,34:2154-2161. Dosument

5. The EUROCARE II Study
   Berrino F.; Gatta G.; Chessa E.; Valente F.; Capocaccia R.
   European Journal of Cancer 1998,34:2139-2153. Document

4. Survival of Adult Cancer Patients in Europe Diagnosed from 1978-1989:
   The EUROCARE II Study
   Coebergh J.W.W.; Sant M.; Berrino F.; Verdecchia A.
   European Journal of Cancer 1998,34:2137-2138. Document

 (top...)

EUROCARE-1

3. The cure of colon cancer: results from the Eurocare Study
   Verdecchia A.; De Angelis R.; Capocaccia R.; Sant M.; Micheli A.; Gatta G.
   International Journal of Cancer 1998,77:322-329. Document

2. Comparison of colon-cancer survival among european countries:
   the EUROCARE study
   Sant M.; Capocaccia R.; Verdecchia V.; Gatta G.; Micheli A.; Mariotto A.; Hakulinen T.; Berrino F.; EUROCARE Working Group.
   International Journal of Cancer 1995,63:43-48. Document

1. Survival of cancer patients in Europe: the EUROCARE Study
   Berrino F.; Sant M.; Verdecchia V.; Capocaccia R.; Hakulinen T.; Estéve J.(editors)
   IARC Scientific Publication 1995,132.

 (top...)